用可穿戴设备和机器学习,把糖尿病前期分型并定制个性化生活方式干预。
Use of Continuous Glucose Monitoring with Machine Learning to Identify Metabolic Subphenotypes and Inform Precision Lifestyle Changes
- 通过连续血糖监测数据训练模型,精准预测胰岛素抵抗和胰岛功能。
- 不同人对食物的血糖反应差异大,可作为代谢亚型的生物标志物。
- 结合作息与运动习惯,实现针对具体代谢缺陷的精准干预。
基于静态血糖阈值对糖尿病和糖尿病前期的分类掩盖了胰岛素抵抗、β细胞功能障碍及肠促胰素缺乏等病理异质性。本综述表明,连续血糖监测(CGM)与可穿戴技术推动了非侵入性动态代谢表型分析的范式转变。研究显示,机器学习模型能利用家庭环境中CGM支持的口服葡萄糖耐量试验的高分辨率血糖数据,准确预测肌肉胰岛素抵抗和β细胞功能的金标准指标。该个性化表征延伸至真实世界营养场景,个体对标准化餐食(如土豆与葡萄)的餐后血糖反应差异,可作为代谢亚型的生物标志物。此外,整合可穿戴数据发现,日常饮食、睡眠与体力活动模式(尤其是时间)与特定代谢功能障碍密切相关,有助于制定精准生活方式干预策略。膳食缓解措施对餐后血糖反应的改善效果亦具有表型依赖性。综合来看,CGM可将早期糖代谢紊乱的复杂性解构为明确且可行动的亚型,超越单纯血糖控制,为针对性营养、行为与药物策略提供依据,开启精准糖尿病预防的新纪元。
原文摘要 · Abstract (English)
The classification of diabetes and prediabetes by static glucose thresholds obscures the pathophysiological dysglycemia heterogeneity, primarily driven by insulin resistance (IR), beta-cell dysfunction, and incretin deficiency. This review demonstrates that continuous glucose monitoring and wearable technologies enable a paradigm shift towards non-invasive, dynamic metabolic phenotyping. We show evidence that machine learning models can leverage high-resolution glucose data from at-home, CGM-enabled oral glucose tolerance tests to accurately predict gold-standard measures of muscle IR and beta-cell function. This personalized characterization extends to real-world nutrition, where an individual's unique postprandial glycemic response (PPGR) to standardized meals, such as the relative glucose spike to potatoes versus grapes, could serve as a biomarker for their metabolic subtype. Moreover, integrating wearable data reveals that habitual diet, sleep, and physical activity patterns, particularly their timing, are uniquely associated with specific metabolic dysfunctions, informing precision lifestyle interventions. The efficacy of dietary mitigators in attenuating PPGR is also shown to be phenotype-dependent. Collectively, this evidence demonstrates that CGM can deconstruct the complexity of early dysglycemia into distinct, actionable subphenotypes. This approach moves beyond simple glycemic control, paving the way for targeted nutritional, behavioral, and pharmacological strategies tailored to an individual's core metabolic defects, thereby paving the way for a new era of precision diabetes prevention.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。